Injective (INJ) is currently priced at $2.96, showing a modest 24-hour change of 2.11%, indicating some positive momentum after recent declines. The daily range of $2.90 to $3.02 suggests a relatively tight trading environment, with current price action hovering near the lower end of this range.

The trading volume stands at approximately $39.72 million, representing 13.39% of the market cap, reflecting active investor interest but not excessive speculation. The hourly moving averages indicate a bearish short-term trend, with the 8 SMA at $3.00 and a decline of 1.44%, while the longer-term 144 SMA at $2.91 shows a positive shift of 1.70%.

The 1-hour RSI at 55 indicates that the asset is neither overbought nor oversold, suggesting some equilibrium in buying and selling pressure. However, the 7-day RSI at 49, coupled with the 7, 14, and 30-day price changes being negative, signals a potential underlying weakness in momentum.

With the all-time high of $52.62 reached in March 2024, the current price reflects a significant downturn, leading to skepticism about short-term recovery. The price action, combined with the negative longer-term trends and the proximity to support levels, points to an uncertain outlook.

Given the data, the recommendation is to Hold. Although the current price shows slight recovery signs, the overall trend remains bearish, and the lack of strong buying momentum suggests further consolidation before any potential upward movement.